Editorial
Granisetron transdermal delivery system is effective in the control of chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy (MEC) or highly emetogenic chemotherapy (HEC) in China
Abstract
Chemotherapy-induced nausea and vomiting (CINV) remains the major adverse effect of cancer treatment which impairs patients’ quality of life and affects their compliance with further treatment (1,2).
